Compile Data Set for Download or QSAR

Found 1045 hits with Last Name = 'parker, jr.' and Initial = 'dl'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Coagulation factor XI (Homo sapiens (Human))	BDBM419907 ((S)-2-(1-(3-AMMONIO-1H-INDAZOLE-6-CARBOXAMIDO)-2-P...) Show SMILES Nc1n[nH]c2cc(ccc12)C(=O)N[C@@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1 |r| Show InChI	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	UniChem	US Patent	0.900	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...				US Patent US10472344 (2019) BindingDB Entry DOI: 10.7270/Q2Q52S04
					More data for this Ligand-Target Pair
Coagulation factor XI (Homo sapiens (Human))	BDBM419910 (US10472344, Example 4) Show SMILES NC(=O)c1ccc(s1)C(=O)N[C@@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1 |r| Show InChI InChI=1S/C26H20ClN7O3S/c27-18-7-9-21(33-15-29-31-32-33)19(13-18)17-6-8-22(34(37)14-17)20(12-16-4-2-1-3-5-16)30-26(36)24-11-10-23(38-24)25(28)35/h1-11,13-15,20H,12H2,(H2,28,35)(H,30,36)/t20-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	UniChem	US Patent	1.30	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...				US Patent US10472344 (2019) BindingDB Entry DOI: 10.7270/Q2Q52S04
					More data for this Ligand-Target Pair
Coagulation factor XI (Homo sapiens (Human))	BDBM419908 (US10472344, Example 2) Show SMILES COC(=O)Nc1ccc(cc1)C(=O)N[C@@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1 |r| Show InChI InChI=1S/C29H24ClN7O4/c1-41-29(39)32-23-11-7-20(8-12-23)28(38)33-25(15-19-5-3-2-4-6-19)27-13-9-21(17-37(27)40)24-16-22(30)10-14-26(24)36-18-31-34-35-36/h2-14,16-18,25H,15H2,1H3,(H,32,39)(H,33,38)/t25-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	UniChem	US Patent	3.60	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...				US Patent US10472344 (2019) BindingDB Entry DOI: 10.7270/Q2Q52S04
					More data for this Ligand-Target Pair
Coagulation factor XI (Homo sapiens (Human))	BDBM419912 (US10472344, Example 6) Show SMILES OC(=O)c1ccc(s1)C(=O)N[C@@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1 |r| Show InChI InChI=1S/C26H19ClN6O4S/c27-18-7-9-21(32-15-28-30-31-32)19(13-18)17-6-8-22(33(37)14-17)20(12-16-4-2-1-3-5-16)29-25(34)23-10-11-24(38-23)26(35)36/h1-11,13-15,20H,12H2,(H,29,34)(H,35,36)/t20-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	UniChem	US Patent	6.90	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...				US Patent US10472344 (2019) BindingDB Entry DOI: 10.7270/Q2Q52S04
					More data for this Ligand-Target Pair
Coagulation factor XI (Homo sapiens (Human))	BDBM419913 (US10472344, Example 7) Show SMILES COCC(=O)Nc1ccc(cc1)C(=O)N[C@@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1 |r| Show InChI InChI=1S/C30H26ClN7O4/c1-42-18-29(39)33-24-11-7-21(8-12-24)30(40)34-26(15-20-5-3-2-4-6-20)28-13-9-22(17-38(28)41)25-16-23(31)10-14-27(25)37-19-32-35-36-37/h2-14,16-17,19,26H,15,18H2,1H3,(H,33,39)(H,34,40)/t26-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	UniChem	US Patent	20	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...				US Patent US10472344 (2019) BindingDB Entry DOI: 10.7270/Q2Q52S04
					More data for this Ligand-Target Pair
Kallikrein-1 (Homo sapiens (Human))	BDBM419907 ((S)-2-(1-(3-AMMONIO-1H-INDAZOLE-6-CARBOXAMIDO)-2-P...) Show SMILES Nc1n[nH]c2cc(ccc12)C(=O)N[C@@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1 |r| Show InChI	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	UniChem	US Patent	25	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description Kallikrein determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; Fishe...				US Patent US10472344 (2019) BindingDB Entry DOI: 10.7270/Q2Q52S04
					More data for this Ligand-Target Pair
Kallikrein-1 (Homo sapiens (Human))	BDBM419910 (US10472344, Example 4) Show SMILES NC(=O)c1ccc(s1)C(=O)N[C@@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1 |r| Show InChI InChI=1S/C26H20ClN7O3S/c27-18-7-9-21(33-15-29-31-32-33)19(13-18)17-6-8-22(34(37)14-17)20(12-16-4-2-1-3-5-16)30-26(36)24-11-10-23(38-24)25(28)35/h1-11,13-15,20H,12H2,(H2,28,35)(H,30,36)/t20-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	UniChem	US Patent	36	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description Kallikrein determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; Fishe...				US Patent US10472344 (2019) BindingDB Entry DOI: 10.7270/Q2Q52S04
					More data for this Ligand-Target Pair
Coagulation factor XI (Homo sapiens (Human))	BDBM419911 (US10472344, Example 5) Show SMILES OC(=O)c1ccc(cc1)C(=O)NC(Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1 Show InChI InChI=1S/C28H21ClN6O4/c29-22-11-13-25(34-17-30-32-33-34)23(15-22)21-10-12-26(35(39)16-21)24(14-18-4-2-1-3-5-18)31-27(36)19-6-8-20(9-7-19)28(37)38/h1-13,15-17,24H,14H2,(H,31,36)(H,37,38)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	UniChem	US Patent	83	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...				US Patent US10472344 (2019) BindingDB Entry DOI: 10.7270/Q2Q52S04
					More data for this Ligand-Target Pair
Kallikrein-1 (Homo sapiens (Human))	BDBM419908 (US10472344, Example 2) Show SMILES COC(=O)Nc1ccc(cc1)C(=O)N[C@@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1 |r| Show InChI InChI=1S/C29H24ClN7O4/c1-41-29(39)32-23-11-7-20(8-12-23)28(38)33-25(15-19-5-3-2-4-6-19)27-13-9-21(17-37(27)40)24-16-22(30)10-14-26(24)36-18-31-34-35-36/h2-14,16-18,25H,15H2,1H3,(H,32,39)(H,33,38)/t25-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	UniChem	US Patent	105	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description Kallikrein determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; Fishe...				US Patent US10472344 (2019) BindingDB Entry DOI: 10.7270/Q2Q52S04
					More data for this Ligand-Target Pair
Coagulation factor XI (Homo sapiens (Human))	BDBM419909 (US10472344, Example 3) Show SMILES COC(=O)Nc1cccc(c1)C(=O)NC(Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1 Show InChI InChI=1S/C29H24ClN7O4/c1-41-29(39)32-23-9-5-8-20(15-23)28(38)33-25(14-19-6-3-2-4-7-19)27-12-10-21(17-37(27)40)24-16-22(30)11-13-26(24)36-18-31-34-35-36/h2-13,15-18,25H,14H2,1H3,(H,32,39)(H,33,38)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	UniChem	US Patent	144	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...				US Patent US10472344 (2019) BindingDB Entry DOI: 10.7270/Q2Q52S04
					More data for this Ligand-Target Pair
Kallikrein-1 (Homo sapiens (Human))	BDBM419912 (US10472344, Example 6) Show SMILES OC(=O)c1ccc(s1)C(=O)N[C@@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1 |r| Show InChI InChI=1S/C26H19ClN6O4S/c27-18-7-9-21(32-15-28-30-31-32)19(13-18)17-6-8-22(33(37)14-17)20(12-16-4-2-1-3-5-16)29-25(34)23-10-11-24(38-23)26(35)36/h1-11,13-15,20H,12H2,(H,29,34)(H,35,36)/t20-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	UniChem	US Patent	219	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description Kallikrein determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; Fishe...				US Patent US10472344 (2019) BindingDB Entry DOI: 10.7270/Q2Q52S04
					More data for this Ligand-Target Pair
Kallikrein-1 (Homo sapiens (Human))	BDBM419913 (US10472344, Example 7) Show SMILES COCC(=O)Nc1ccc(cc1)C(=O)N[C@@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1 |r| Show InChI InChI=1S/C30H26ClN7O4/c1-42-18-29(39)33-24-11-7-21(8-12-24)30(40)34-26(15-20-5-3-2-4-6-20)28-13-9-22(17-38(28)41)25-16-23(31)10-14-27(25)37-19-32-35-36-37/h2-14,16-17,19,26H,15,18H2,1H3,(H,33,39)(H,34,40)/t26-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	UniChem	US Patent	516	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description Kallikrein determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; Fishe...				US Patent US10472344 (2019) BindingDB Entry DOI: 10.7270/Q2Q52S04
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM406013 (US10351558, Example 188) Show SMILES Cc1ccc2n3C[C@@](CCc3c(C(O)=O)c2c1)(NC(=O)c1ccc(cc1Cl)-n1cnn(C)c1=O)c1cccc(F)c1 |r| Show InChI InChI=1S/C30H25ClFN5O4/c1-17-6-9-24-22(12-17)26(28(39)40)25-10-11-30(15-36(24)25,18-4-3-5-19(32)13-18)34-27(38)21-8-7-20(14-23(21)31)37-16-33-35(2)29(37)41/h3-9,12-14,16H,10-11,15H2,1-2H3,(H,34,38)(H,39,40)/t30-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.509	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405953 (US10351558, Example 128) Show SMILES Cc1ccc2n3C[C@@](CCc3c(C(O)=O)c2c1)(NC(=O)c1ccc(cc1)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C29H25N5O3/c1-19-7-12-24-23(15-19)26(28(36)37)25-13-14-29(16-34(24)25,21-5-3-2-4-6-21)32-27(35)20-8-10-22(11-9-20)33-17-30-31-18-33/h2-12,15,17-18H,13-14,16H2,1H3,(H,32,35)(H,36,37)/t29-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.596	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405993 (US10351558, Example 168) Show SMILES COc1ncn(n1)-c1ccc(C(=O)N[C@@]2(CCc3c(C(O)=O)c4cc(C)ccc4n3C2)c2ccccc2)c(Cl)c1 |r| Show InChI InChI=1S/C30H26ClN5O4/c1-18-8-11-24-22(14-18)26(28(38)39)25-12-13-30(16-35(24)25,19-6-4-3-5-7-19)33-27(37)21-10-9-20(15-23(21)31)36-17-32-29(34-36)40-2/h3-11,14-15,17H,12-13,16H2,1-2H3,(H,33,37)(H,38,39)/t30-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.636	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405996 (US10351558, Example 171) Show SMILES Cc1ncn(n1)-c1ccc(C(=O)N[C@@]2(CCc3c(C(O)=O)c4cc(C)ccc4n3C2)c2cccc(F)c2)c(Cl)c1 |r| Show InChI InChI=1S/C30H25ClFN5O3/c1-17-6-9-25-23(12-17)27(29(39)40)26-10-11-30(15-36(25)26,19-4-3-5-20(32)13-19)34-28(38)22-8-7-21(14-24(22)31)37-16-33-18(2)35-37/h3-9,12-14,16H,10-11,15H2,1-2H3,(H,34,38)(H,39,40)/t30-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.791	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405985 (US10351558, Example 160) Show SMILES Cc1ccc2n3C[C@@](CCc3c(\C=C\C(O)=O)c2c1)(NC(=O)c1ccc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C31H26ClN5O3/c1-20-7-11-27-25(15-20)23(10-12-29(38)39)28-13-14-31(17-37(27)28,21-5-3-2-4-6-21)35-30(40)24-9-8-22(16-26(24)32)36-18-33-34-19-36/h2-12,15-16,18-19H,13-14,17H2,1H3,(H,35,40)(H,38,39)/b12-10+/t31-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.820	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405974 (US10351558, Example 149) Show SMILES Cc1ncn(n1)-c1ccc(C(=O)N[C@@]2(CCc3c(C(O)=O)c4cc(C)ccc4n3C2)c2ccccc2)c(Cl)c1 |r| Show InChI InChI=1S/C30H26ClN5O3/c1-18-8-11-25-23(14-18)27(29(38)39)26-12-13-30(16-35(25)26,20-6-4-3-5-7-20)33-28(37)22-10-9-21(15-24(22)31)36-17-32-19(2)34-36/h3-11,14-15,17H,12-13,16H2,1-2H3,(H,33,37)(H,38,39)/t30-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.03	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405944 (US10351558, Example 119) Show SMILES OC(=O)Cn1c2CC[C@](Cc2c2ccc(Cl)cc12)(NC(=O)c1ccc(cc1Cl)-n1cnnc1)c1cccc(F)c1 |r| Show InChI InChI=1S/C29H22Cl2FN5O3/c30-18-4-6-21-23-13-29(17-2-1-3-19(32)10-17,9-8-25(23)37(14-27(38)39)26(21)11-18)35-28(40)22-7-5-20(12-24(22)31)36-15-33-34-16-36/h1-7,10-12,15-16H,8-9,13-14H2,(H,35,40)(H,38,39)/t29-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.17	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM406007 (US10351558, Example 182) Show SMILES Cc1ncn(n1)-c1ccc(C(=O)N[C@@]2(CCc3c(\C=C\C(O)=O)c4cc(C)ccc4n3C2)c2ccccc2)c(Cl)c1 |r| Show InChI InChI=1S/C32H28ClN5O3/c1-20-8-12-28-26(16-20)24(11-13-30(39)40)29-14-15-32(18-37(28)29,22-6-4-3-5-7-22)35-31(41)25-10-9-23(17-27(25)33)38-19-34-21(2)36-38/h3-13,16-17,19H,14-15,18H2,1-2H3,(H,35,41)(H,39,40)/b13-11+/t32-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.18	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM50126915 (CHEMBL3629110 | US10351558, Example 138) Show SMILES Cc1ccc2n3C[C@@](CCc3c(C(N)=O)c2c1)(NC(=O)c1ccc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C29H25ClN6O2/c1-18-7-10-24-22(13-18)26(27(31)37)25-11-12-29(15-36(24)25,19-5-3-2-4-6-19)34-28(38)21-9-8-20(14-23(21)30)35-16-32-33-17-35/h2-10,13-14,16-17H,11-12,15H2,1H3,(H2,31,37)(H,34,38)/t29-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.25	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405882 (US10351558, Example 57) Show SMILES Cc1ccc2n3C[C@@](CCc3nc2c1)(NC(=O)c1ccc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C27H23ClN6O/c1-18-7-10-24-23(13-18)31-25-11-12-27(15-34(24)25,19-5-3-2-4-6-19)32-26(35)21-9-8-20(14-22(21)28)33-16-29-30-17-33/h2-10,13-14,16-17H,11-12,15H2,1H3,(H,32,35)/t27-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.42	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM50126956 (CHEMBL3628961 | US10351558, Example 174) Show SMILES Cc1ccc2n3C[C@@](CCc3c(C(N)=O)c2c1)(NC(=O)c1c(Cl)cc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C29H24Cl2N6O2/c1-17-7-8-23-20(11-17)25(27(32)38)24-9-10-29(14-37(23)24,18-5-3-2-4-6-18)35-28(39)26-21(30)12-19(13-22(26)31)36-15-33-34-16-36/h2-8,11-13,15-16H,9-10,14H2,1H3,(H2,32,38)(H,35,39)/t29-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.45	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM406014 (US10351558, Example 189) Show SMILES Cc1ccc2n3C[C@@](CCc3c(-c3cncc(N)c3)c2c1)(NC(=O)c1ccc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C33H28ClN7O/c1-21-7-10-29-27(13-21)31(22-14-24(35)17-36-16-22)30-11-12-33(18-41(29)30,23-5-3-2-4-6-23)39-32(42)26-9-8-25(15-28(26)34)40-19-37-38-20-40/h2-10,13-17,19-20H,11-12,18,35H2,1H3,(H,39,42)/t33-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.58	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM406031 (US10351558, Example 206) Show SMILES Cc1ccc2n3C[C@@](CCc3c(-c3cnc(nc3)C3CC3)c2c1)(NC(=O)c1ccc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C35H30ClN7O/c1-22-7-12-30-28(15-22)32(24-17-37-33(38-18-24)23-8-9-23)31-13-14-35(19-43(30)31,25-5-3-2-4-6-25)41-34(44)27-11-10-26(16-29(27)36)42-20-39-40-21-42/h2-7,10-12,15-18,20-21,23H,8-9,13-14,19H2,1H3,(H,41,44)/t35-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.58	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405975 (US10351558, Example 150) Show SMILES Cc1nncn1-c1ccc(C(=O)N[C@@]2(CCc3c(C(O)=O)c4cc(C)ccc4n3C2)c2ccccc2)c(Cl)c1 |r| Show InChI InChI=1S/C30H26ClN5O3/c1-18-8-11-25-23(14-18)27(29(38)39)26-12-13-30(16-35(25)26,20-6-4-3-5-7-20)33-28(37)22-10-9-21(15-24(22)31)36-17-32-34-19(36)2/h3-11,14-15,17H,12-13,16H2,1-2H3,(H,33,37)(H,38,39)/t30-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.60	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405978 (US10351558, Example 153) Show SMILES Cc1ccc2n3C[C@@](CCc3c(C=O)c2c1)(NC(=O)c1c(Cl)cc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C29H23Cl2N5O2/c1-18-7-8-25-21(11-18)22(14-37)26-9-10-29(15-36(25)26,19-5-3-2-4-6-19)34-28(38)27-23(30)12-20(13-24(27)31)35-16-32-33-17-35/h2-8,11-14,16-17H,9-10,15H2,1H3,(H,34,38)/t29-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.61	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405994 (US10351558, Example 169) Show SMILES Cc1ccc2n3C[C@@](CCc3c(C(O)=O)c2c1)(NC(=O)c1ccc(cc1Cl)-n1cnn(C)c1=O)c1ccccc1 |r| Show InChI InChI=1S/C30H26ClN5O4/c1-18-8-11-24-22(14-18)26(28(38)39)25-12-13-30(16-35(24)25,19-6-4-3-5-7-19)33-27(37)21-10-9-20(15-23(21)31)36-17-32-34(2)29(36)40/h3-11,14-15,17H,12-13,16H2,1-2H3,(H,33,37)(H,38,39)/t30-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.68	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM406028 (US10351558, Example 203) Show SMILES COc1ncc(cn1)-c1c2CC[C@](Cn2c2ccc(C)cc12)(NC(=O)c1ccc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C33H28ClN7O2/c1-21-8-11-28-26(14-21)30(22-16-35-32(43-2)36-17-22)29-12-13-33(18-41(28)29,23-6-4-3-5-7-23)39-31(42)25-10-9-24(15-27(25)34)40-19-37-38-20-40/h3-11,14-17,19-20H,12-13,18H2,1-2H3,(H,39,42)/t33-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.71	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM50126855 (CHEMBL3628962 | US10351558, Example 173) Show SMILES Cc1ccc2n3C[C@@](CCc3c(\C=N\O)c2c1)(NC(=O)c1c(Cl)cc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C29H24Cl2N6O2/c1-18-7-8-25-21(11-18)22(14-34-39)26-9-10-29(15-37(25)26,19-5-3-2-4-6-19)35-28(38)27-23(30)12-20(13-24(27)31)36-16-32-33-17-36/h2-8,11-14,16-17,39H,9-10,15H2,1H3,(H,35,38)/b34-14+/t29-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL KEGG PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.75	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405862 (US10351558, Example 37) Show SMILES Cc1ncn(n1)-c1cc(Cl)c(C(=O)NC2(CCc3nn4cc(C)ccc4c3C2)c2cccc(C)c2)c(Cl)c1 Show InChI InChI=1S/C29H26Cl2N6O/c1-17-5-4-6-20(11-17)29(10-9-25-22(14-29)26-8-7-18(2)15-36(26)35-25)33-28(38)27-23(30)12-21(13-24(27)31)37-16-32-19(3)34-37/h4-8,11-13,15-16H,9-10,14H2,1-3H3,(H,33,38)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.84	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405969 (US10351558, Example 144) Show SMILES CC(=O)c1c2CC[C@](Cn2c2ccc(C)cc12)(NC(=O)c1ccc(cc1Cl)-n1cnc(C)n1)c1ccccc1 |r| Show InChI InChI=1S/C31H28ClN5O2/c1-19-9-12-27-25(15-19)29(20(2)38)28-13-14-31(17-36(27)28,22-7-5-4-6-8-22)34-30(39)24-11-10-23(16-26(24)32)37-18-33-21(3)35-37/h4-12,15-16,18H,13-14,17H2,1-3H3,(H,34,39)/t31-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.85	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM406022 (US10351558, Example 197) Show SMILES COC(=O)Cc1c2CC[C@](Cn2c2ccc(C)cc12)(NC(=O)c1c(Cl)cc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C31H27Cl2N5O3/c1-19-8-9-26-22(12-19)23(15-28(39)41-2)27-10-11-31(16-38(26)27,20-6-4-3-5-7-20)36-30(40)29-24(32)13-21(14-25(29)33)37-17-34-35-18-37/h3-9,12-14,17-18H,10-11,15-16H2,1-2H3,(H,36,40)/t31-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.87	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM406000 (US10351558, Example 175) Show SMILES Cc1ccc2n3C[C@@](CCc3c(C(=O)C(F)F)c2c1)(NC(=O)c1ccc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C30H24ClF2N5O2/c1-18-7-10-24-22(13-18)26(27(39)28(32)33)25-11-12-30(15-38(24)25,19-5-3-2-4-6-19)36-29(40)21-9-8-20(14-23(21)31)37-16-34-35-17-37/h2-10,13-14,16-17,28H,11-12,15H2,1H3,(H,36,40)/t30-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.99	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405960 (& 146 | US10351558, Example 135) Show SMILES CC(=O)c1c2CC[C@](Cn2c2ccc(C)cc12)(NC(=O)c1ccc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C30H26ClN5O2/c1-19-8-11-26-24(14-19)28(20(2)37)27-12-13-30(16-36(26)27,21-6-4-3-5-7-21)34-29(38)23-10-9-22(15-25(23)31)35-17-32-33-18-35/h3-11,14-15,17-18H,12-13,16H2,1-2H3,(H,34,38)/t30-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.01	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405982 (US10351558, Example 157) Show SMILES Cc1ccc2n3C[C@@](CCc3c(\C=C\C(N)=O)c2c1)(NC(=O)c1ccc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C31H27ClN6O2/c1-20-7-11-27-25(15-20)23(10-12-29(33)39)28-13-14-31(17-38(27)28,21-5-3-2-4-6-21)36-30(40)24-9-8-22(16-26(24)32)37-18-34-35-19-37/h2-12,15-16,18-19H,13-14,17H2,1H3,(H2,33,39)(H,36,40)/b12-10+/t31-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.03	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405972 (US10351558, Example 147) Show SMILES Cc1nncn1-c1ccc(C(=O)N[C@@]2(CCc3c(C(N)=O)c4cc(C)ccc4n3C2)c2ccccc2)c(Cl)c1 |r| Show InChI InChI=1S/C30H27ClN6O2/c1-18-8-11-25-23(14-18)27(28(32)38)26-12-13-30(16-36(25)26,20-6-4-3-5-7-20)34-29(39)22-10-9-21(15-24(22)31)37-17-33-35-19(37)2/h3-11,14-15,17H,12-13,16H2,1-2H3,(H2,32,38)(H,34,39)/t30-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.05	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405838 (US10351558, Example 13) Show SMILES Cc1ncn(n1)-c1ccc(C(=O)NC2(CCc3nn4cc(C)ccc4c3C2)c2cccc(C)c2)c(Cl)c1 Show InChI InChI=1S/C29H27ClN6O/c1-18-5-4-6-21(13-18)29(12-11-26-24(15-29)27-10-7-19(2)16-35(27)34-26)32-28(37)23-9-8-22(14-25(23)30)36-17-31-20(3)33-36/h4-10,13-14,16-17H,11-12,15H2,1-3H3,(H,32,37)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.08	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405981 (US10351558, Example 156) Show SMILES Cc1ccc2n3C[C@@](CCc3c(-c3nnn[nH]3)c2c1)(NC(=O)c1ccc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid PDB UniChem	PDB US Patent	n/a	n/a	2.38	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair				3D Structure (crystal)
Coagulation factor IX (Homo sapiens (Human))	BDBM405962 (US10351558, Example 137) Show SMILES Cc1ccc2n3C[C@@](CCc3c(\C=N\O)c2c1)(NC(=O)c1ccc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C29H25ClN6O2/c1-19-7-10-26-23(13-19)24(15-33-38)27-11-12-29(16-36(26)27,20-5-3-2-4-6-20)34-28(37)22-9-8-21(14-25(22)30)35-17-31-32-18-35/h2-10,13-15,17-18,38H,11-12,16H2,1H3,(H,34,37)/b33-15+/t29-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	2.38	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405847 (US10351558, Example 22) Show SMILES Cc1ccc(O)c2c3C[C@@](C)(CCc3nn12)NC(=O)c1ccc(cc1Cl)-n1cnc2ccc(cc12)C(N)=O |r| Show InChI InChI=1S/C28H25ClN6O3/c1-15-3-8-24(36)25-19-13-28(2,10-9-21(19)33-35(15)25)32-27(38)18-6-5-17(12-20(18)29)34-14-31-22-7-4-16(26(30)37)11-23(22)34/h3-8,11-12,14,36H,9-10,13H2,1-2H3,(H2,30,37)(H,32,38)/t28-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.38	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405848 (US10351558, Example 23) Show SMILES Cc1ccc(O)c2c3C[C@@](C)(CCc3nn12)NC(=O)c1ccc(cc1Cl)-n1cnc2cc(ccc12)C(N)=O |r| Show InChI InChI=1S/C28H25ClN6O3/c1-15-3-8-24(36)25-19-13-28(2,10-9-21(19)33-35(15)25)32-27(38)18-6-5-17(12-20(18)29)34-14-31-22-11-16(26(30)37)4-7-23(22)34/h3-8,11-12,14,36H,9-10,13H2,1-2H3,(H2,30,37)(H,32,38)/t28-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.44	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405955 (US10351558, Example 130) Show SMILES Cc1ccc2n3C[C@@](CCc3c(C(O)=O)c2c1)(NC(=O)c1ccc(cn1)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C28H24N6O3/c1-18-7-10-23-21(13-18)25(27(36)37)24-11-12-28(15-34(23)24,19-5-3-2-4-6-19)32-26(35)22-9-8-20(14-29-22)33-16-30-31-17-33/h2-10,13-14,16-17H,11-12,15H2,1H3,(H,32,35)(H,36,37)/t28-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.53	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405986 (US10351558, Example 161 | US10351558, Example 164) Show SMILES Cc1ccc2n3C[C@@](CCc3c(CCC(N)=O)c2c1)(NC(=O)c1ccc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C31H29ClN6O2/c1-20-7-11-27-25(15-20)23(10-12-29(33)39)28-13-14-31(17-38(27)28,21-5-3-2-4-6-21)36-30(40)24-9-8-22(16-26(24)32)37-18-34-35-19-37/h2-9,11,15-16,18-19H,10,12-14,17H2,1H3,(H2,33,39)(H,36,40)/t31-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.55	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405910 (US10351558, Example 85) Show SMILES Cc1ccc2n3CC(CC(F)(F)c3nc2c1)(NC(=O)c1ccc(cc1Cl)-n1cnnc1)c1ccccc1 Show InChI InChI=1S/C27H21ClF2N6O/c1-17-7-10-23-22(11-17)33-25-27(29,30)13-26(14-36(23)25,18-5-3-2-4-6-18)34-24(37)20-9-8-19(12-21(20)28)35-15-31-32-16-35/h2-12,15-16H,13-14H2,1H3,(H,34,37)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.56	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405988 (US10351558, Example 163) Show SMILES Cc1ncn(n1)-c1cc(C)c(C(=O)N[C@@]2(CCc3c(C(N)=O)c4cc(C)ccc4n3C2)c2ccccc2)c(Cl)c1 |r| Show InChI InChI=1S/C31H29ClN6O2/c1-18-9-10-25-23(13-18)28(29(33)39)26-11-12-31(16-37(25)26,21-7-5-4-6-8-21)35-30(40)27-19(2)14-22(15-24(27)32)38-17-34-20(3)36-38/h4-10,13-15,17H,11-12,16H2,1-3H3,(H2,33,39)(H,35,40)/t31-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.59	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM50126923 (CHEMBL3628832 | US10351558, Example 67) Show SMILES Cc1ncn(n1)-c1ccc(C(=O)N[C@@]2(CCc3nc4cc(C)ccc4n3C2)c2ccccc2)c(Cl)c1 |r| Show InChI InChI=1S/C28H25ClN6O/c1-18-8-11-25-24(14-18)31-26-12-13-28(16-34(25)26,20-6-4-3-5-7-20)32-27(36)22-10-9-21(15-23(22)29)35-17-30-19(2)33-35/h3-11,14-15,17H,12-13,16H2,1-2H3,(H,32,36)/t28-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2.61	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405853 (US10351558, Example 28) Show SMILES Cc1ncn(n1)-c1ccc(C(=O)NC2(CCc3nn4cc(C)ccc4c3C2)c2cccc(Cl)c2)c(Cl)c1 Show InChI InChI=1S/C28H24Cl2N6O/c1-17-6-9-26-23-14-28(19-4-3-5-20(29)12-19,11-10-25(23)34-35(26)15-17)32-27(37)22-8-7-21(13-24(22)30)36-16-31-18(2)33-36/h3-9,12-13,15-16H,10-11,14H2,1-2H3,(H,32,37)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.63	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM406025 (US10351558, Example 200) Show SMILES COc1ccc(cn1)-c1c2CC[C@](Cn2c2ccc(C)cc12)(NC(=O)c1ccc(cc1Cl)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C34H29ClN6O2/c1-22-8-12-29-27(16-22)32(23-9-13-31(43-2)36-18-23)30-14-15-34(19-41(29)30,24-6-4-3-5-7-24)39-33(42)26-11-10-25(17-28(26)35)40-20-37-38-21-40/h3-13,16-18,20-21H,14-15,19H2,1-2H3,(H,39,42)/t34-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.63	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM405952 (US10351558, Example 127) Show SMILES Cc1ccc2n3C[C@@](CCc3c(C(N)=O)c2c1)(NC(=O)c1ccc(cc1)-n1cnnc1)c1ccccc1 |r| Show InChI InChI=1S/C29H26N6O2/c1-19-7-12-24-23(15-19)26(27(30)36)25-13-14-29(16-35(24)25,21-5-3-2-4-6-21)33-28(37)20-8-10-22(11-9-20)34-17-31-32-18-34/h2-12,15,17-18H,13-14,16H2,1H3,(H2,30,36)(H,33,37)/t29-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.64	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp US Patent					Assay Description TBD				US Patent US10351558 (2019) BindingDB Entry DOI: 10.7270/Q2SX6GKR
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 1045 total )  |  Next  |  Last  >>

Jump to: